>

# EXALENZ Z Score

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Investing Opportunities.
 Symbol Refresh

## EXALENZ Z Score Analysis

Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
 Z Score = Sum Of 5 Factors
 EXALENZ BIOSCIENCE Z Score = 0
 First Factor = 1.2 * ( Working Capital / Total Assets )
 Second Factor = 1.4 * ( Retained Earnings / Total Assets )
 Thrid Factor = 3.3 * ( EBITAD / Total Assets )
 Fouth Factor = 0.6 * ( Market Value of Equity / Total Liabilities )
 Fifth Factor = 0.99 * ( Revenue / Total Assets )

To calculate Z-Score one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1 indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.Compare to competition
EXALENZ BIOSCIENCE has Z Score of 0.0. This is 100.0% lower than that of the Healthcare sector, and 100.0% lower than that of Diagnostics & Research industry, The Z Score for all stocks is 100.0% higher than the company.

## Did you try this?

Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
 All  Next Launch Module

## EXALENZ current financial ratios

 Return On Asset (25.36) Profit Margin (39.93) Operating Margin (33.86) Current Valuation 149.38 M Shares Outstanding 27.08 M Price to Book 4,694 Revenue 13.25 M Gross Profit 5.75 M EBITDA (3.72 M) Net Income (5.29 M) Cash and Equivalents 2.96 M Cash per Share 0.11 Total Debt 6.59 M Debt to Equity 0.18 Current Ratio 1.94 Book Value Per Share (0.13) Cash Flow from Operations (5.99 M) Earnings Per Share (0.21) Number of Employees 17 Beta 1.05 Market Capitalization 14.14 B Total Asset 44 M Retained Earnings (281 M) Working Capital 26 M Current Asset 37 M Current Liabilities 11 M

## Current Sentiment - EXEN

### EXALENZ BIOSCIENCE Investor Sentiment

Macroaxis portfolio users are insensible in their opinion about investing in EXALENZ BIOSCIENCE. What is your opinion about investing in EXALENZ BIOSCIENCE? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
 Skip